Triglyceride genetics is complex, involving multiple genes such as APOE, LPL, APOC3, and GCKR. Certain variants are associated with higher or lower triglyceride levels, but they typically explain only a small fraction of individual variation. Consumer DNA tests claiming to reveal 'triglyceride genetics' often rely on single SNPs with weak effect sizes and rarely provide clinically actionable results. The evidence is mostly mechanistic or from GWAS, not from randomized trials showing benefit for dietary adjustments. Lifestyle factors—diet (sugar, saturated fats), exercise, alcohol intake, and weight—have a much stronger impact on triglyceride levels than common genetic variants. Elevated triglycerides should always be evaluated by a physician, especially regarding cardiovascular risk. Genetic testing may offer supplementary insight but should not replace professional medical advice. Be cautious of overblown claims from direct-to-consumer tests.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-796e6a01863ec3a609340263